Cancer Family
Hepatobiliary Neoplasm
CI-CAN-00000198Explore in graph →
Non-malignant1,187 active trials17 approved drugs42 evidence items
- NCIt
- C8614
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000198Explore in graph →
Clinical trials
5,266 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04837742 | The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy | completed | N/A | 30 | National Taiwan University HospitalOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT02351765 | ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers(ABC-08) | completed | Phase 1 | 21 | The Christie NHS Foundation TrustOTHER | 1 | May 17, 2023 |
| clinicaltrials |
| NCT04681274 | Phenotyping Liver Cancer Registry(PHELICAR) | completed | — | 2,429 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT01845337 | Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine(TOFFEE) | completed | Phase 2 | 59 | University of EdinburghOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT03841201 | Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma | completed | Phase 2 | 50 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT03841110 | FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors | completed | Phase 1 | 37 | Fate TherapeuticsINDUSTRY | 1 | May 1, 2023 | clinicaltrials |
| NCT04641637 | Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC | completed | N/A | 40 | Chinese University of Hong KongOTHER | 1 | May 1, 2023 | clinicaltrials |
| NCT02853474 | Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy(EPIC-1511) | completed | Phase 3 | 480 | Centre Oscar LambretOTHER | 1 | Apr 26, 2023 | clinicaltrials |
| NCT02094625 | NAC to Prevent Cisplatin-induced Hearing Loss | completed | Phase 1 | 52 | Children's Hospital Los AngelesOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT03586973 | A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 34 | TakedaINDUSTRY | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04970212 | Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures | completed | — | 65 | Techsomed Medical Technologies LTDINDUSTRY | 1 | Apr 18, 2023 | clinicaltrials |
| NCT01943318 | Boramae Hospital Liver Cirrhosis Patient Cohort Study | completed | — | 500 | Seoul National University Boramae HospitalOTHER | 1 | Apr 12, 2023 | clinicaltrials |
| NCT05804799 | Liver CT Dose Reduction With Deep Learning Based Reconstruction | completed | — | 300 | Seoul National University HospitalOTHER | 2 | Apr 12, 2023 | clinicaltrials |
| NCT00587067 | A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy | completed | Phase 2 | 34 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT04653818 | HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial(RCT) | completed | Phase 4 | 84 | Alexandria UniversityOTHER | 1 | Apr 4, 2023 | clinicaltrials |
| NCT03849469 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors(DUET-4) | completed | Phase 1 | 78 | Xencor, Inc.INDUSTRY | 1 | Mar 30, 2023 | clinicaltrials |
| NCT03895970 | Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors | completed | Phase 2 | 32 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT02821754 | A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) | completed | Phase 2 | 54 | National Cancer Institute (NCI)NIH | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05772403 | Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver Disease | completed | — | 100 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT03801915 | Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers | completed | Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2023 | clinicaltrials |
| NCT04124991 | Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC(SOLID) | completed | Phase 1 / Phase 2 | 24 | Seoul National University HospitalOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT01192971 | A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma(HCC) | completed | Phase 2 | 121 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05739110 | HCC Staging Modified by Tumor Micronecrosis | completed | — | 1,100 | Zhejiang UniversityOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02683200 | MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer | completed | Early Phase 1 | 21 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT05028439 | RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma | completed | N/A | 70 | First People's Hospital of HangzhouOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT04246125 | Patient Skin Dose in Interventional Radiology(DPPRI) | completed | — | 87 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05732181 | The Role of 5% Lidocaine Patches in the Pain Control of Hepatocellular Carcinoma Patients Receiving Radiofrequency Ablation | completed | N/A | 154 | National Cheng-Kung University HospitalOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05475054 | Impact of Minimally Invasive and Open Liver Surgery in Different BMI-classes(MILSOBES) | completed | — | 9,963 | Fondazione Poliambulanza Istituto OspedalieroOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05729230 | PAtient-PHYsician Relationship Assessment(PAPHYRA) | completed | — | 50 | Erasme University HospitalOTHER | 1 | Feb 15, 2023 | clinicaltrials |
| NCT04248816 | Hepatocellular Carcinoma Surveillance in Cirrhotics | completed | N/A | 615 | University of PennsylvaniaOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05352204 | Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas | completed | — | 900 | Zhejiang UniversityOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT03248375 | Impact of Y90 Radiation Segmentectomy on HCC | completed | N/A | 29 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05370001 | Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet Ventilation | completed | N/A | 26 | Region StockholmOTHER_GOV | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05720195 | ALBI and PALBI Scores and HCC Prognosis | completed | — | 645 | Sohag UniversityOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT04194801 | A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 26 | CStone PharmaceuticalsINDUSTRY | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05638048 | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | completed | N/A | 270 | Junyan ZhaoOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT05471674 | Neoadjuvant Anti-PD1 in HCC | completed | Phase 2 | 20 | Dr Tan-to CHEUNGOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT03980288 | 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3 | completed | Phase 1 | 6 | Zhejiang UniversityOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT02438436 | Simo Decoction and Gum Chewing for Bowel Activity(SD/GC-HCC) | completed | Phase 3 | 180 | Guangxi Medical UniversityOTHER | 1 | Jan 30, 2023 | clinicaltrials |
| NCT02654028 | Association Between Autologous Transfusion and Recurrence-free Survival in Patients With HCC After Resection(AT/HCC) | completed | N/A | 618 | Guangxi Medical UniversityOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT04476082 | Nutrition in Gastrointestinal Tumors(NutriGIT) | completed | — | 66 | University Medicine GreifswaldOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT02435433 | A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein(REACH-2) | completed | Phase 3 | 399 | Eli Lilly and CompanyINDUSTRY | 20 | Jan 20, 2023 | clinicaltrials |
| NCT04430842 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | completed | Phase 1 | 15 | Quadriga Biosciences, Inc.INDUSTRY | 1 | Jan 18, 2023 | clinicaltrials |
| NCT03867916 | Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients | completed | N/A | 106 | University of California, San FranciscoOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05681234 | Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma | completed | N/A | 30 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT03648073 | [68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 12 | University of Alabama at BirminghamOTHER | 1 | Jan 10, 2023 | clinicaltrials |
| NCT05225207 | A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants | completed | — | 658 | Eisai Korea Inc.INDUSTRY | 1 | Jan 9, 2023 | clinicaltrials |
| NCT01642186 | Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | completed | Phase 2 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT04763707 | Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis | completed | — | 87 | Sohag UniversityOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT02794805 | Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis | completed | Phase 2 | 74 | Meridian Bioscience, Inc.INDUSTRY | 1 | Dec 20, 2022 | clinicaltrials |
Data updated 24 days agoSource updated May 26, 2023source: clinicaltrials